-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
POINT Biopharma Global Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q3 2023.
- POINT Biopharma Global Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $871K, a 383% increase year-over-year.
- POINT Biopharma Global Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was $30.6M, a 5862% increase year-over-year.
- POINT Biopharma Global Inc. annual Income Tax Expense (Benefit) for 2022 was $31.3M, a 10138% increase from 2021.
- POINT Biopharma Global Inc. annual Income Tax Expense (Benefit) for 2021 was $306K, a 248% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)